FDA 483 - Akan Biosciences Inc - September 30, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Akan Biosciences, Inc. in Gaithersburg, MD, a human tissue establishment, was cited for significant deficiencies during an FDA inspection. The firm failed to adequately test and screen donors for communicable disease agents, and its adipose tissue product, Ayama, was shipped without proper donor eligibility determination and quarantine. Additionally, the inspection revealed a lack of validated manufacturing processes, established CGTP procedures, software validation, and a comprehensive quality program for handling complaints.
ID · ea9fe2d4-3f67-42bc-9ad4-b5647d202a38